Results 141 to 150 of about 5,935 (185)

Acute Life-Threatening Glycoprotein IIb/IIIa Inhibitor-Induced Thrombocytopenia Following Percutaneous Coronary Intervention (PCI): A Case Report and Review of the Literature. [PDF]

Cureus
Souman B, Wyant C, Parekh Z, Shokoohi C, Valina A.   +4 more
europepmc   +1 more source

Bleeding in Antiplatelet Therapy: A Narrative Review of Clinical Evidence and the Roles of Pharmacists and Nurses. [PDF]

Rev Cardiovasc Med
Xu F, Zhang ZH, Li LC, Mao KL, Huang ZY.
europepmc   +1 more source

Development of Reference Intervals for the TEG 6s, a Point-of-Care Viscoelastic Assay, in Dogs. [PDF]

Vet Clin Pathol
Wilkinson AR, Conner BJ, Serpa PBS.
europepmc   +1 more source

Abciximab reduces mortality in diabetics following percutaneous coronary intervention [PDF]

Journal of the American College of Cardiology, 2000
OBJECTIVESWe sought to determine whether abciximab therapy at the time of percutaneous coronary intervention (PCI) would favorably affect one-year mortality in patients with diabetes.BACKGROUNDDiabetics are known to have increased late mortality ...
Stephen Ellis
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Abciximab

Reactions Weekly, 2002
Deepak Bhatt, A Lincoff
  +5 more sources

Abciximab

Reactions Weekly, 2013
  +5 more sources

Abciximab

Reactions Weekly, 2011
  +4 more sources

Abciximab

Reactions Weekly, 2018
  +4 more sources

Abciximab

Reactions Weekly, 2008
  +5 more sources